Regulated APIs Capitalize on Purisys's leadership in regulated cannabinoid and psychedelic APIs and its FDA-inspected GMP facilities to supply pharma and biotech clients needing compliant, scalable API and intermediate manufacturing for regulated substances, with regulatory documentation support.

Analytical Standards Promote the in-stock reference standards and comprehensive analytical data to labs and CROs, offering method development, qualification, and solid-state formulation support to de-risk early-stage programs.

Full CDMO Scope Offer end-to-end development for preclinical to commercial APIs, including HPAPI and labile molecule development, with cGMP manufacturing in place to support small-volume and orphan drug programs.

Partnership Track Record Demonstrate credibility through recent collaborations to scale manufacturing for opioid use disorder candidates and other biotech programs, using case studies to win new engagements.

Global Capabilities Leverage the global reach and Siegfried Group backing to provide cross-border supply, worldwide reference standards distribution, and a resilient supply chain for regulated substances.